Capitolis Advisors’s Biogen BIIB Stock Holding History

Capitolis Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-10,958	Closed	-$2.63M	–	190
2021 Q4	$2.63M	Hold	10,958	–	–	0.02%	379
2021 Q3	$2.96M	Buy	+10,958	New	+$3.59M	0.03%	267
2021 Q2	–	Sell	-9,291	Closed	-$2.6M	–	413
2021 Q1	$2.6M	Hold	9,291	–	–	0.05%	224
2020 Q4	$2.27M	Buy	+9,291	New	+$2.4M	0.04%	298

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

Capitolis Advisors's BIIB Position: Q1 2022 in Review

Capitolis Advisors sold out of Biogen (BIIB) in Q1 2022, closing a stake of 10,958 shares — an estimated $2.63M sold.

Capitolis Advisors first reported a position in BIIB in Q4 2020 and held it in 4 quarters. The position peaked at $2.96M in Q3 2021. 951 funds tracked by Wall St. Rank hold BIIB as of Q1 2022.

Capitolis Advisors reported no remaining Biogen position as of Q1 2022 after selling out during the quarter.
Capitolis Advisors sold 10,958 Biogen shares in Q1 2022, an estimated $2.63M.
Capitolis Advisors first reported a position in Biogen in Q4 2020 and held it in 4 quarters.
Capitolis Advisors's Biogen position peaked at $2.96M in Q3 2021.
951 funds tracked by Wall St. Rank held Biogen as of Q1 2022.

Based on Capitolis Advisors's 13F filing for Q1 2022, filed 12 May 2022.